/
BMRA
$1.77+$0.02 (+1.14%)live
Held · Bookmarked
0 · 0
portfolios · users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Market cap
$5.4M
3M shares
52-week range
$1.73 – $4.60
1% from low
Sector
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Exchange
NASDAQ
CS
Borrow rate
0.85%
Easy to borrow
Price (6 mo)
Loading chart…
Change$-30.31
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $5.6M | $5.2M | $6.7M | $7.2M | $18.9M | $5.3M | $5.4M | $5.3M |
| Cost of revenue | $3.8M | $3.9M | $4.9M | $6.8M | $15.9M | $4.9M | $4.8M | $4.8M |
| Gross profit | $1.8M | $1.3M | $1.8M | $366.3K | $3.0M | $446.0K | $611.0K | $498.0K |
| Gross margin | 31.5% | 24.8% | 26.6% | 5.1% | 15.8% | 8.4% | 11.3% | 9.4% |
| R&D | $1.4M | $1.7M | $1.9M | $2.2M | $1.8M | $1.6M | $1.5M | $1.0M |
| Operating income | −$1.5M | −$2.4M | −$2.4M | −$7.5M | −$4.5M | −$7.2M | −$6.4M | −$5.1M |
| EBITDA | −$1.2M | −$2.2M | −$1.9M | −$7.1M | −$3.9M | −$6.7M | −$5.6M | −$4.6M |
| Net income | −$1.5M | −$2.4M | −$2.3M | −$7.4M | −$4.5M | −$7.1M | −$6.0M | −$5.0M |
| Net margin | -26.3% | -46.0% | -34.9% | -103.4% | -24.0% | -133.7% | -110.4% | -93.6% |
| EPS (diluted) | -0.17 | -0.26 | -0.23 | -0.54 | -0.36 | -0.50 | -0.36 | -2.16 |
Annual figures · source: Financial Modeling Prep
Peer comparison
BIOMERICA INC
Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. The Company manages its operations as a single operating and reportable segment, which focus on the development, manufacture, marketing, and sale of diagnostic products. The majority of the company's revenue is earned from the Asia, and also has its presence in Europe, North America, Middle East and South America.
www.biomerica.com- Employees
- 54
- IPO / List date
- Sep 26, 1978
- HQ
- IRVINE, CA
Held by traders on TradeandTell
No one on the platform currently holds BMRA.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in BMRA as of their last filing.
Insider activity (SEC Form 4)
Stock splits
| Execution date | Ratio |
|---|---|
| 2025-04-21 | 1-for-8reverse |
Recent trades on TradeandTell
No one on the platform has traded BMRA yet.
